Netflix Inc NFLX Bullish LongTerm Case Persists Amid PostEarnings and MADriven Volatility Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus POCI Precision falls 119 after Q1 2026 earnings report a 023 per share loss with no analyst estimates available